Wednesday, December 06, 2017 11:48:59 PM
Actually they were filed 11/21/17 and this repeated post misrepresents it as new information and continues the documented lie about insolvency. Your own previous post acknowledged that you are not using the accepted definition of insolvent yet the error is not retracted or addressed when identified
"LOW LIGHTS: Cash around 1k
"Related Third Party Payable". $416 k
Liabilities $886K!! "
Notice that the other $300k in assets are conveniently ignored
"Losses accumulated almost $ 3 million"
Of course any knowledgeable investor recognizes that this figure is a tax loss carry forward when the company generates a profit
"Here is the best part--net loss for quarter of $25k--THEY DONT EVEN PUT IN ANYTHING FOR REVENUE!!!!!"
I disagree on the best part. That will be when Sucanon is again confirmed highly efficacious in treatment of type 2 and prediabetes with no adverse side effects as it has been shown in previous studies: 370 subject double blinded placebo controlled study where Sucanon outperformed Glyburide and a 97 subject 12 week study in prediabetics in which 84% showed a normalized HbA1C level at its conclusion. Neither showed adverse side effects, with a desirable side effect of weight loss in contrast to weight gain observed in most all other oral diabetic medications. Patt 2 of the best part will be Sucanons approval and sale in India, one of the largest and fastest growing population of diabetics in the world.
Jacob J. Rosenblum on what every lawyer knows.
“If the facts are against you, hammer the law. If the law is against you, hammer the facts. If the fact and the law are against you, hammer opposing counsel."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM